On one hand, for ESCC patients administered neoadjuvant chemoradiation, NRP1 was significantly upregulated in the SD group compared with levels in the PR group (p < 0.05, Figure 5C). The gene discussed is NRP1; the disease is esophageal squamous cell carcinoma.